Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery
NCT ID: NCT03687853
Last Updated: 2018-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2017-01-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
of liver metastasis following curative resection of pancreatic cancer
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Translational Research on Locally Advanced Pancreatic Adenocarcinoma
NCT03009253
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
NCT06873178
A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma
NCT02706782
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
NCT03398291
Divestment for Artery-involved Pancreatic Cancer
NCT03443921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intrahepatic Arterial Infusion chemotherapy
chemotherapy through intrahepatic arterial Infusion is one of the most widely used liver tumor treatments.
Intrahepatic Arterial Infusion
Intrahepatic Arterial Infusion chemotherapy is one of the most widely used liver tumor treatments.
control
chemotherapy through Peripheral venous is one of the regularly used method.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrahepatic Arterial Infusion
Intrahepatic Arterial Infusion chemotherapy is one of the most widely used liver tumor treatments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
dianrong xiu, doctor
Role: STUDY_CHAIR
Peking University Third Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of General Surgery,Peking University Third Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HAI PDCA 1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.